DFL24498

DRUG2 trials

Sponsors

Dompé Farmaceutici S.p.A

Conditions

Atopic KeratoconjunctivitisDry Eye Disease (DED)

Phase 2

An Exploratory Efficacy and Safety Study of DFL24498 Topical Ophthalmic Solution Compared With Vehicle in Participants With Dry Eye Disease

RecruitingNCT07503886

Dompé Farmaceutici S.p.ADry Eye Disease (DED)

Start: 2026-05-12End: 2027-02-07Target: 417Updated: 2026-06-26

Phase 3

An Efficacy and Safety Study of DFL24498 in the Treatment of AKC

RecruitingNCT07395232

Dompé Farmaceutici S.p.AAtopic Keratoconjunctivitis

Start: 2025-12-01End: 2027-05-01Target: 138Updated: 2026-04-20